Seòmar agus comataidhean

That is a broad range right across the industry. What responsibility do you take for the packaging that your members use, which no doubt is bright and colourful and attractive to young people, and for that range of flavours that Emma Harper was referring to—bubble gum, candyfloss and so on—which a lot of very well-established vaping retailers carry?

Actually, I am going to come back to you with University of Glasgow figures. First, however, I will go to Paul Sweeney and then to James Dornan.

We need to move on—we have a lot of questions.

We have six minutes left for this evidence session, and three members have supplementaries. If members and the panel can be concise, we will probably get them all in.

Our third agenda item is consideration of two affirmative instruments.

The first instrument is the draft National Health Service (Scotland) Act 1978 (Independent Health Care) Modification Order 2024. The purpose of the instrument is to enable Healthcare Improvement Scotland to regulate independent clinics where services are provided by pharmacists and pharmacy technicians; to amend the definition of “independent medical agency” to cover services that are provided by dental practitioners, registered nurses, registered midwives, dental care professionals, pharmacists and pharmacy technicians, which will include wholly online services in Scotland; and to enable Healthcare Improvement Scotland to cancel the registration of independent healthcare services that fail to pay their continuation fees.

The second instrument is the draft Healthcare Improvement Scotland (Inspections) Amendment Regulations 2024. The purpose of the instrument is to allow inspectors who are authorised by Healthcare Improvement Scotland under section 10K of the National Health Service Scotland Act 1978 to inspect medical records. The policy note further states that the current list of professions restricts who HIS is able to draw upon to inspect medical records as part of its inspections. Currently, the ability to inspect medical records as part of inspections that are undertaken by HIS is restricted to medical practitioners, registered nurses, pharmacists and registered dentists.

The Delegated Powers and Law Reform Committee considered the instruments at its meeting on 7 May 2024 and made no recommendations.

Today, we will have an evidence session with the Cabinet Secretary for Health and Social Care and supporting officials on both instruments. Once we have had all our questions answered, we will proceed to a formal debate on the motions.

I welcome to the committee Neil Gray, Cabinet Secretary for Health and Social Care. He is accompanied by Scottish Government officials. Lorraine Alcock is team lead in safety, openness and learning; Kirndeep Kaur is a solicitor in the legal directorate; and Robert Law is a senior policy manager in safety, openness and learning.

I invite the cabinet secretary to make a brief opening statement.

The next item on our agenda is consideration of one negative instrument. The purpose of the instrument is to enable Healthcare Improvement Scotland to prescribe the maximum fees that it may impose in respect of independent medical agencies, to raise the maximum fees that may be imposed on all independent healthcare services in respect of applications for registration or cancelling of registration of independent healthcare services, the annual continuation of any such registration, and applications for the variation or removal of a condition of registration.

The Delegated Powers and Law Reform Committee considered the instrument at its meeting on 7 May 2024 and made no recommendations. No motion to annul has been lodged.

Given that no member has indicated that they wish to comment, I propose that the committee make no recommendation in relation to the instrument. Is that agreed?

Members indicated agreement.

Sandesh Gulhane has a very brief supplementary question to take us up to 11:40, and it will require a very brief answer.

Thank you, Mr Dunne. We will have a brief suspension to change witnesses.

We will now take evidence from our second panel of witnesses on the bill. I welcome Sheila Duffy, who is the chief executive of ASH Scotland, and Dr Garth Reid, who is a consultant in public health at Public Health Scotland. We will move straight to questions.

Well, I tend to disagree. I will come back to you with some research.